Idiosyncratic DILI (iDILI) is a rare and unpredictable event that is responsible for drug removal from the market. Prediction of iDILI occurrence at early phase of drug development is extremely challenging.

PredictCan Biotechnologies uses a state-of-the-art 3D individual-centric model that contains hepatocytes, hepatic stellate cells, macrophages, and dendritic cells to accurately detect immune-mediated and non-immune-mediated iDILI.

Our technology allows us to generate cohorts of individuals and to identify which subject is at risk for iDILI occurrence when exposed to a given drug, and also to gain host factor-associated toxicology insights including age and sex.